Biomerica: Rises on European approval for COVID-19 test

Biomerica

12/01/2021 13:45

** Shares of biomedical co  BMRA.O  up 25% at $6.5 premarket
- set for best day in nearly a year
    ** Co says it has received CE Mark for use in Europe for its
COVID-19 Rapid Antigen Test  urn:newsml:reuters.com:*:nGNX9vVKML
    ** Co has received its first European orders and plans to
ship first part of these orders in next few weeks - BMRA
    ** Biomerica's new COVID-19 test is portable and provides
results in 15 minutes 
    ** Up to Tuesday's close, stock had risen 67% in last 12
months 

 (Reporting by Dania Nadeem in Bengaluru)
 ((Dania.Nadeem@thomsonreuters.com;))